HipraHipra was founded in Spain in 1954 and is dedicated to researching, manufacturing and marketing veterinary products, including livestock vaccines and pharmacological specialities. Hipra actively participates in the creation, innovation, and promotion of products and services that improve the health and performance of livestock. Hipra have a High Containment Biological Unit near Girona, Spain where R&D activities are performed in the fields of Bacteriology and Virology according to the strictest Good Laboratory Practice (GPL) regulations. There are separate production units for Bacterial, Viral cell production and Viral egg production. Research and Development of new products is one of Hipra’s highest priorities, as shown by the 9% of sales revenue invested into R&D each year. Website: www.hipra.com HuvepharmaHuvepharma is a fast-growing global pharmaceutical company with a focus on manufacturing and marketing medicated feed additives for farmed animals. The company also manufactures enzymes, mainly for inclusion in pig and poultry feed. Huvepharma is a privately-owned company headquartered in Sofia, Bulgaria, with the Sales & Marketing division located in Belgium. Originally a state owned enterprise until privatised in 1999, the wholly owned manufacturing subsidiary still retains the historic company name of Biovet. Expansionary growth during the past decade included upgrading and purchasing new manufacturing facilities, and acquiring global feed additive brands and product registrations from Intervet and Merial. A seismic shift has been made from private label packing towards directly supplying customers with Huvepharma branded products. A substantial investment in registering new products globally in recent years has meant Huvepharma is now challenging the multi-nationals for the global lead in key antibacterial products for poultry, pigs, and cattle. Huvepharma has an extensive R&D program, excellent quality assurance and packaged goods facilities, and employs highly skilled staff with extensive experience in the veterinary pharmaceuticals and animal production. The Company owns primary manufacturing plants in four European locations, with another facility in the USA, and is the largest manufacturer of ionophores such as monensin and salinomycin in Europe. Huvepharma’s ionophores premixes are renowned for excellent handling properties due to uniform granulation and low dust, and superior bioavailability. Biovet has EU GMP certification for sterile injectables, and powder and medicated premix production facilities. All major medicated feed additives products including Coxidin (monensin) have Brand Specific Approval under the stringent European Foods Safety Authority registration standards. The Biovet plant and several antibacterial feed additive products such as Salocin (salinomycin), and GainPro (flavomycin) are also FDA approved. Huvapharma and Biovet are also certified by SGS for GMP + HACCP Animal Feed Sector (OVOCOM), and quality management and environmental protection ISO 9001:2000/ISO 14001:1996. Website: www.huvepharma.com
SyntexSyntex S.A. is a privately owned Argentinian company. It was founded in 1935 with the aim of manufacturing products of biological and semi-synthetic origin for the pharmaceutical and veterinary industry. The quality of Syntex’s products is well known and widely respected across the globe. For decades Syntex has been supplying active ingredients for human medicines in Japan, USA and Europe. In the veterinary pharmaceutical sector Syntex is the market leader in reproductive hormones in the major cattle markets of Argentina, Uruguay, Brazil, and exports to over 15 other countries including Canada. Syntex invests in numerous cattle clinical trials including oestrus synchrony programs, blanket insemination trials, and embryo transfer. The Company is currently expanding and renewing the veterinary pharmaceutical plant facilities in Buenos Aires as part of an export led expansion program.
IAHInternational Animal Health Products was established in 1987 by Chris and Lynne Lawlor as the marketing and manufacturing vehicle of Hardock and Keymix. Souter Rural was then acquired, and the Farnam brand purchased from Pitman Moore. International Animal Health Products are committed to bringing the highest quality at the best price to market. The company is wholly Australian owned and privately operated. In 2009 IAH purchased several veterinary medicines from Parnell Technologies; including CopperEx, Butin Paste, Bromotrimidine, Trimidine and Koagulon. The following year the leading copper injectable brand Cue was also acquired from Parnell. AgriHealth represents IAH as sales agent for their registered veterinary medicines in NZ including Cue Injection, CopperEx Injection, CopperEx Bullets and Koagulon.
|
 |
DIB-V progesterone insert
Eficur Injection
Hiprabovis-3 cattle vaccine |
